NOV Mono expands operation in Germany
Pumps specialist aims to grow Mono Universal Parts across Europe
Svetla Laskova will be located in Berlin and Werner Potrafke will be working near Bochum. Both have language skills and sales and business development experience in the industrial and engineering sectors.
According to Martyn Turner, Universal Parts product manager at Mono, there is a significant market for progressing cavity (PC) pumps in Germany and until recently buyers have had to purchase replacement parts from the OEM.
‘Mono manufactures a range of Universal Parts designed for use in other branded PC pumps and these two new appointments will help us to promote the benefits of the brand and our PC pump technology to the waste water market in Germany,’ he said.
The full range of Mono Universal Parts includes rotors, stators, coupling rods, shafts, pins/bushes, seals and drive train assemblies for use in Seepex, Netzsch, PCM, Allweiler, Robbins & Myers, Bornemann and Orbit pumps.
Based in Manchester, UK, NOV Mono Group has more than 700 authorised distributors worldwide and employs around 750 people.
You may also like
Manufacturing
BD and Suttons Creek collaborate to streamline combination product development for pharma and biotech
The new strategic collaboration will help pharmaceutical and biotech companies reduce development risk and regulatory complexity across drug-device combination products, including biologics and GLP-1 therapies
Manufacturing
Miltenyi Biotec and CHA Biotech collaborate on BaEV lentiviral vector platform
The pair will work to enhance CAR NK cell therapy manufacturing efficiency, combining Miltenyi Bioindustry's baboon envelope lentiviral vector platform with CHA Biotech's NK cell research expertise to improve gene delivery, scalability and cost of goods
Manufacturing
Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market
Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA